OSEBX1 945,09+0,00 %
EQNR349,90+0,00 %
DNB281,10+0,00 %
MOWI202,20+0,00 %
Brent$102,12+0,84 %
Gold$4 713,70+0,41 %
USD/NOK9,3025+0,03 %
EUR/NOK10,9311+0,05 %
SPX7 365,12+1,46 %
NDX28 599,17+2,08 %
MARKETS CLOSED · LAST TRADE Thu 03:29 UTC
386056

EPS Creative Health Technology Group Ltd

Apparel & AccessoriesVerified
Score breakdown
Profitability+23Sentiment+30Missing signals-3
Quality breakdown
Key fields100Profile38Conclusion94AI synthesis40Observations3

The company maintains a strong liquidity position, with a current ratio of 2.89 and cash and equivalents amounting to HKD 135.7 million, which is significantly higher than its total liabilities of HKD 216.2 million. The low debt-to-equity ratio of 0.06 indicates a conservative capital structure, with minimal reliance on long-term debt [doc:HA-latest]. Profitability metrics show a return on equity of 31.97% and a return on assets of 11.45%, both of which are strong relative to the typical performance of firms in the Apparel & Accessories industry. The operating margin of 7.66% (calculated from operating income of HKD 41.7 million on revenue of HKD 544.5 million) suggests efficient cost management, although the gross margin of 17.36% (HKD 94.6 million gross profit on HKD 544.5 million revenue) is moderate for the sector [doc:HA-latest]. Revenue is distributed across four segments, with no single segment accounting for a dominant share. The company operates in multiple geographic regions, including Japan, the United States, Europe, and Hong Kong, but the input data does not provide specific revenue concentration by region or segment [doc:HA-latest]. The company's outlook for the current fiscal year shows a stable revenue trajectory, with no significant growth or contraction expected. The free cash flow of HKD 40.5 million and capital expenditure of HKD 5.7 million suggest a balanced approach to reinvestment and cash preservation [doc:HA-latest]. The risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt load and strong cash position reduce the likelihood of near-term dilution or liquidity pressure. The absence of recent equity issuance or ATM programs further supports the low dilution potential [doc:HA-latest]. No recent filings or transcripts were provided in the input data, so no specific events can be cited to inform the company's recent strategic or operational developments [doc:HA-latest].

Profile
CompanyEPS Creative Health Technology Group Ltd
Ticker3860.HK
SectorConsumer Cyclicals
BusinessCyclical Consumer Products
Industry groupCyclical Consumer Products
IndustryApparel & Accessories
AI analysis

Business. EPS Creative Health Technology Group Ltd is an investment holding company primarily engaged in the sale of knitwear apparel products across four segments: Womenswear, Menswear, Kidswear, and Other, which includes knitted facial masks, hats, and mufflers, with sales in Japan, the United States, Europe, Hong Kong, and other regions [doc:HA-latest].

Classification. EPS Creative Health Technology Group Ltd is classified under the Consumer Cyclicals economic sector, Cyclical Consumer Products business sector, and Apparel & Accessories industry, with a classification confidence of 0.92 [doc:verified market data].

The company maintains a strong liquidity position, with a current ratio of 2.89 and cash and equivalents amounting to HKD 135.7 million, which is significantly higher than its total liabilities of HKD 216.2 million. The low debt-to-equity ratio of 0.06 indicates a conservative capital structure, with minimal reliance on long-term debt [doc:HA-latest]. Profitability metrics show a return on equity of 31.97% and a return on assets of 11.45%, both of which are strong relative to the typical performance of firms in the Apparel & Accessories industry. The operating margin of 7.66% (calculated from operating income of HKD 41.7 million on revenue of HKD 544.5 million) suggests efficient cost management, although the gross margin of 17.36% (HKD 94.6 million gross profit on HKD 544.5 million revenue) is moderate for the sector [doc:HA-latest]. Revenue is distributed across four segments, with no single segment accounting for a dominant share. The company operates in multiple geographic regions, including Japan, the United States, Europe, and Hong Kong, but the input data does not provide specific revenue concentration by region or segment [doc:HA-latest]. The company's outlook for the current fiscal year shows a stable revenue trajectory, with no significant growth or contraction expected. The free cash flow of HKD 40.5 million and capital expenditure of HKD 5.7 million suggest a balanced approach to reinvestment and cash preservation [doc:HA-latest]. The risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt load and strong cash position reduce the likelihood of near-term dilution or liquidity pressure. The absence of recent equity issuance or ATM programs further supports the low dilution potential [doc:HA-latest]. No recent filings or transcripts were provided in the input data, so no specific events can be cited to inform the company's recent strategic or operational developments [doc:HA-latest].
Key takeaways
  • EPS Creative Health Technology Group Ltd maintains a strong liquidity position with a current ratio of 2.89 and HKD 135.7 million in cash and equivalents.
  • The company's return on equity of 31.97% and return on assets of 11.45% indicate strong profitability relative to its asset base.
  • The company operates in a diversified geographic footprint, including Japan, the United States, Europe, and Hong Kong, with no single region dominating revenue.
  • The company's capital structure is conservative, with a low debt-to-equity ratio of 0.06 and minimal long-term debt exposure.
  • No immediate liquidity or dilution risks were identified, and the company's free cash flow of HKD 40.5 million supports financial flexibility.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyHKD
Revenue$544.5M
Gross profit$94.6M
Operating income$41.7M
Net income$38.6M
R&D
SG&A
D&A
SBC
Operating cash flow-$17.9M
CapEx-$5.7M
Free cash flow$40.5M
Total assets$336.8M
Total liabilities$216.2M
Total equity$120.7M
Cash & equivalents$135.7M
Long-term debt$6.7M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$544.5M$41.7M$38.6M$40.5M
FY-1$644.6M-$17.0M-$22.1M-$17.5M
FY-2$452.9M-$42.4M-$45.7M-$48.2M
FY-3$519.9M-$18.1M-$22.6M-$23.0M
FY-4$405.4M$7.3M$6.5M$9.0M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$336.8M$120.7M$135.7M
FY-1$429.9M$65.4M$115.5M
FY-2$227.5M$87.6M$131.5M
FY-3$296.6M$131.3M$208.1M
FY-4$151.2M$133.1M
PeriodOCFCapExFCFSBC
FY0-$17.9M-$5.7M$40.5M
FY-1-$28.6M-$5.0M-$17.5M
FY-2-$38.1M-$2.4M-$48.2M
FY-3$4.0M-$283.0k-$23.0M
FY-4-$12.4M-$525.0k$9.0M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$120.7M
Net cash$129.0M
Current ratio2.9
Debt/Equity0.1
ROA11.5%
ROE32.0%
Cash conversion-46.0%
CapEx/Revenue-1.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Apparel & Accessories · cohort 2 companies
Metric3860Activity
Op margin7.7%6.6% medp25 4.6% · p75 8.7%above median
Net margin7.1%3.7% medp25 2.0% · p75 5.5%top quartile
Gross margin17.4%57.5% medp25 57.5% · p75 57.5%bottom quartile
CapEx / revenue-1.1%1.1% medp25 0.9% · p75 1.4%bottom quartile
Debt / equity6.0%124.3% medp25 86.1% · p75 162.6%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-03 09:44 UTC#55f42823
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 09:45 UTCJob: f2c816cd